Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Forssmann, Sāmī Saʿīd, Related Peptides (1996)
VIP, PACAP, and related peptides : second international symposium
M. Trotz, S. Said (1993)
Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitroRegulatory Peptides, 48
M. Lardelli, U. Lendahl (1994)
Generating bacteriophage lambda sublibraries enriched for rare clones.BioTechniques, 16 3
U. Gether, T. Johansen, T. Schwartz (1993)
Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.The Journal of biological chemistry, 268 11
S. Barik, M. Galinski (1991)
"Megaprimer" method of PCR: increased template concentration improves yield.BioTechniques, 10 4
S. Ollerenshaw, Deborah Jarvis, Ann Woolcock, Colin Sullivan, T. Scheibner (1989)
Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma.The New England journal of medicine, 320 19
J. Vilardaga, P. Deneef, E. Dipaolo, Alex Bollen, M. Waelbroeck, P. Robberecht (1995)
Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.Biochemical and biophysical research communications, 211 3
S. Ollerenshaw, D. Jarvis, A. Woolcock, C. Sullivan, T. Scheibner (1989)
Absence of immunoreactive intestinal polypeptide in tissue from the lungs of patients with asthmaNew Engl. J. Med., 320
D. Patel, Y. Kong, S. Sreedharan (1995)
Molecular cloning and expression of a human secretin receptor.Molecular pharmacology, 47 3
Beatrice Beaubien, J. Tippins, Howard Morris (1984)
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide.Biochemical and biophysical research communications, 125 1
M. Holtmann, E. Hadac, L. Miller (1995)
Critical Contributions of Amino-terminal Extracellular Domains in Agonist Binding and Activation of Secretin and Vasoactive Intestinal Polypeptide Receptors. STUDIES OF CHIMERIC RECEPTORS (*)The Journal of Biological Chemistry, 270
G. Segre, S. Goldring (1993)
Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor familyTrends in Endocrinology & Metabolism, 4
J. Buggy, J. Livingston, D. Rabin, H. Yoo-Warren (1995)
Glucagon·Glucagon-like Peptide I Receptor Chimeras Reveal Domains That Determine Specificity of Glucagon Binding (*)The Journal of Biological Chemistry, 270
S. Hjorth, K. Adelhorst, B. Pedersen, O. Kirk, T. Schwartz (1994)
Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.The Journal of biological chemistry, 269 48
G. Pont-Kingdon (1994)
Construction of chimeric molecules by a two-step recombinant PCR method.BioTechniques, 16 6
J. Tams, S. Knudsen, Jan Fahrenkrug (1998)
Proposed arrangement of the seven transmembrane helices in the secretin receptor family.Receptors & channels, 5 2
R. Horton, Z. Cai, S. Ho, L. Pease (2013)
Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction.BioTechniques, 8 5
M. König, L. Mahan, J. Marsg, J. Fink, M. Brownstein (1991)
Method for identifying ligands that bind to cloned Gs- or Gi-coupled receptorsMolecular and Cellular Neuroscience, 2
G. Sarkar, S. Sommer (1990)
The "megaprimer" method of site-directed mutagenesis.BioTechniques, 8 4
B. Lefebvre, P. Formstecher, P. Lefebvre (1995)
Improvement of the gene splicing overlap (SOE) method.BioTechniques, 19 2
P. Gourlet, J. Vilardaga, P. Neef, M. Waelbroeck, A. Vandermeers, P. Robberecht (1996)
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptorsPeptides, 17
D. Bolin, J. Michalewsky, M. Wasserman, M. O'Donnell (1995)
Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthmaBiopolymers, 37
Receptors for the neurotransmitter and neuroendocrine peptides, vasoactive intesinal peptide (VIP) and secretin, both belong to the Type B subfamily of G-protein-coupled receptors. This group is evolutionally as well as structurally distinct from the much larger Type A, or rhodopsin-type, subfamily. We have mapped the ligand-activating epitopes of the human VIP1 receptor by the use of hybrid receptor constructs with the human secretin receptor. Twelve chimeras were synthesized by successively replacing portions of the former receptor with corresponding portions of the latter receptor, or by interchanging the first extracellular loops. Each of the different chimeric receptor DNAs were then expressed in murine reporter cells, and their ability to activate cAMP production was investigated on stimulation with the respective natural peptide ligands. We stimulated the reporter cells with secretin or VIP following transient expression of the receptor chimeras. The experiments indicated that there are two molecular domains of importance for the recognition and activation of these peptides, namely, the inner portion of the extracellular tail and the first extracellular loop of the two receptors.
Journal of Molecular Neuroscience – Springer Journals
Published: May 24, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.